Cboe Files for Staked Injective ETF Amid Growing Crypto Regulation
- The Chicago Board Options Exchange (Cboe) submitted a filing to list shares of Canary Capital’s staked Injective (INJ) ETF.
- Canary Capital filed an S-1 application with the SEC on July 17, aiming to accrue staking rewards through validation services.
- If approved, this would be the third staked altcoin ETF, following those for Solana (SOL) and Ether (ETH).
- The SEC has not yet acknowledged the filings but typically responds within a timeframe of about 30 to 45 days.
- INJ is currently trading at $15.10, down over 71% from its all-time high of $52 recorded in March.
The approval of this ETF could enhance liquidity and visibility for the Injective protocol’s governance token, potentially attracting traditional investors. The favorable regulatory environment under the Trump administration supports innovation in crypto investment vehicles.
If successful, this ETF could help INJ recover from its significant decline since March, as it aims to leverage staking rewards effectively.(Source)
